
Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the eight research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a …